Health Sector Updates: Global Deals and Investments at a Glance
Recent health news highlights include Guinea's agreement with the US on a $143 million health project, US Medicare's planned sanctions on Elevance Health, and uniQure's setback from FDA's trial data feedback. Meanwhile, Smith & Nephew supports 2026 forecasts amid challenges, Novo Nordisk expands in Ireland, Target ditches synthetic colors, and Intellia Therapeutics advances heart therapy trials.
In a noteworthy development, Guinea and the United States have formalized a five-year health cooperation agreement with nearly $143 million in joint funding. This marks another bilateral effort by the U.S., which has shifted strategies since dismantling its aid agency last year.
The Centers for Medicare & Medicaid Services have signaled a move to sanction Elevance Health by suspending enrollments in its prescription drug plans effective March 31, 2026, impacting company shares by over 3% premarket.
In corporate news, Smith & Nephew's CEO has affirmed the company's optimistic 2026 outlook despite looming challenges from Middle East tensions and higher tariffs, following a successful turnaround in their orthopaedic division.
Advertisement
ALSO READ
-
Healthcare Workers Stage Protests Over Unmet Demands in PoJK
-
Life-Saving Liver Transplant for Infant at MGM Healthcare Malar
-
Modernisation of Regional Cancer Centre at JIPMER will further expand healthcare capacity: PM Modi in Puducherry.
-
Ayushman Bharat scheme already fulfilling vision of 'accessible, affordable healthcare' for crores of families: PM Modi in Puducherry.
-
We believe that healthcare should be accessible, available, affordable to all: PM Modi in Puducherry.
Google News